95 related articles for article (PubMed ID: 18971117)
1. Cancer as an endocrine problem.
Holly JM; Perks CM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):539-50. PubMed ID: 18971117
[TBL] [Abstract][Full Text] [Related]
2. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine mechanisms in insulin resistance.
Sjöstrand M; Eriksson JW
Mol Cell Endocrinol; 2009 Jan; 297(1-2):104-11. PubMed ID: 18599191
[TBL] [Abstract][Full Text] [Related]
4. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
Cathcart MC; Lysaght J; Pidgeon GP
Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
[TBL] [Abstract][Full Text] [Related]
5. Endocrine dismodulation and cancer.
Portier CJ
Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():43-7. PubMed ID: 12163847
[TBL] [Abstract][Full Text] [Related]
6. The NFkappaB pathway and endocrine-resistant breast cancer.
Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098
[TBL] [Abstract][Full Text] [Related]
7. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.
Bermudez-Silva FJ; Cardinal P; Cota D
J Psychopharmacol; 2012 Jan; 26(1):114-24. PubMed ID: 21824982
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities.
Massarweh S; Schiff R
Clin Cancer Res; 2007 Apr; 13(7):1950-4. PubMed ID: 17404074
[TBL] [Abstract][Full Text] [Related]
12. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
13. Energy restriction controls aging through neuroendocrine signal transduction.
Berner YN; Stern F
Ageing Res Rev; 2004 Apr; 3(2):189-98. PubMed ID: 15177054
[TBL] [Abstract][Full Text] [Related]
14. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
15. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies.
Gerozissis K
Eur J Pharmacol; 2008 May; 585(1):38-49. PubMed ID: 18407262
[TBL] [Abstract][Full Text] [Related]
16. Resistance to endocrine therapy of breast cancer: recent advances and tomorrow's challenges.
Geisler J; Lønning PE
Clin Breast Cancer; 2001 Jan; 1(4):297-308; discussion 309. PubMed ID: 11899352
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Dietary cancer and prevention using antimutagens.
Ferguson LR; Philpott M; Karunasinghe N
Toxicology; 2004 May; 198(1-3):147-59. PubMed ID: 15138038
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ErbB receptor signalling in cancer cells by microRNA.
Barker A; Giles KM; Epis MR; Zhang PM; Kalinowski F; Leedman PJ
Curr Opin Pharmacol; 2010 Dec; 10(6):655-61. PubMed ID: 20864407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
